This study describes a TLR inhibitor peptide 1 (TIP1) that primarily suppresses the downstream signaling mediated by TIR domain-containing adapters in an animal model of lupus and patients with SLE. This evidence concerns the gene TAX1BP3 and systemic lupus erythematosus.